CX is Europe’s largest and longest-running vascular symposium and delivers vascular EDUCATION as it should be

CX raises CONTROVERSIESCHALLENGES the evidence to reach CONSENSUS in a three yearly cycle after discussion involving a world-class faculty and expert audience.

CX uses both live cases and edited cases from leading aortic, peripheral and venous centres to illustrate the techniques and technologies covered in the main CX plenary programme.

CX showcases INNOVATION 15 new product launches in 2018 and similar number set for this year. 70+ exhibitors will exhibit for 3 full days under the glass roof in the Grand Hall, Olympia London. The CX Innovation Showcase and Dragons’ Den highlight the latest exciting early stage technologies.

Finally CX considers the EVIDENCE in the interest of the optimal management of the patient with vascular disease. The CX Special Sessions will focus on the paclitaxel controversy, the draft UK NICE AAA guidelines and the Stroke from Thoracic Endovascular Procedures (STEP) study.

Register now for early bird rates! Click here to register.